Citigroup Inc Seres Therapeutics, Inc. Put Options Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 09, 2024	SELL	$0.93 - $2.15 $46,314 - $107,070	-49,800 Reduced 39.94%	74,900 $104,000
Q3 2023 Nov 09, 2023	SELL	$2.33 - $5.07 $19,805 - $43,095	-8,500 Reduced 6.38%	124,700 $296,000
Q2 2023 Aug 10, 2023	BUY	$4.67 - $6.55 $25,218 - $35,370	5,400 Added 4.23%	133,200 $638,000
Q1 2023 May 11, 2023	BUY	$4.95 - $6.09 $288,585 - $355,047	58,300 Added 83.88%	127,800 $724,000
Q4 2022 Feb 09, 2023	BUY	$5.09 - $9.05 $353,755 - $628,975	69,500 New	69,500 $389,000

46.7M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $102M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.